Ex parte MORIMOTO et al. - Page 11




          Appeal No. 1996-1080                                                        
          Application No. 07/869,111                                                  

          examples also suggest or direct the artisan to various                      
          silylated and 9-oxime derivatives (see examples 3, 4 and 11).               
          Watanabe teaches various substituents at the 9-oxime position               
          that result in protection of that position during methylation               
          (see page 3).  Accordingly, we agree with the examiner’s                    
          position that substitution of the alkenyl and benzyl                        
          substituents taught by Watanabe for the alkyl group                         
          exemplified at the 9-position by Faubl would have been well                 
          within the skill in the art.3  Both Faubl and Watanabe are                  
          directed to antibiotics and methods of protecting various                   
          substituents of erythromycin derivatives.                                   
               For the foregoing reasons, we determine that the examiner              
          has established a prima facie case of obviousness in view of                
          the reference evidence.  As previously noted, appellants have               
          submitted three Declarations by Watanabe to rebut the                       
          examiner’s evidence of obviousness.  The Watanabe I                         
          Declaration and Experiments 7 through 10 of the Watanabe II                 
          Declaration have been submitted by appellants to rebut the                  

               3Conversely, the silyl derivatives of the substituted 9-               
          oximes of Watanabe would have been well within the ordinary                 
          skill in the art given the teaching in Kirk-Othmer of                       
          conventional silylation of hydroxy substituents in                          
          antibiotics.                                                                
                                         11                                           





Page:  Previous  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  Next 

Last modified: November 3, 2007